Apg Asset Management N.V. Sarepta Therapeutics, Inc. Transaction History

Apg Asset Management N.V.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$65.97 - $92.48 $1.29 Million - $1.81 Million	-19,600 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$69.38 - $86.75 $11.2 Million - $14 Million	-161,840 Reduced 89.2%	19,600 $1.29 Million
Q1 2021 May 14, 2021	BUY	$72.25 - $168.95 $2.79 Million - $6.52 Million	38,618 Added 27.04%	181,440 $11.5 Million
Q4 2020 Feb 12, 2021	SELL	$125.56 - $178.74 $441,343 - $628,271	-3,515 Reduced 2.4%	142,822 $19.9 Million
Q3 2020 Nov 12, 2020	BUY	$127.12 - $172.34 $5.58 Million - $7.57 Million	43,907 Added 42.87%	146,337 $17.5 Million
Q2 2020 Aug 14, 2020	SELL	$93.0 - $171.7 $595,386 - $1.1 Million	-6,402 Reduced 5.88%	102,430 $14.6 Million
Q1 2020 May 15, 2020	BUY	$82.38 - $131.64 $8.97 Million - $14.3 Million	108,832 New	108,832 $10.6 Million
Q1 2020 May 14, 2020	SELL	$82.38 - $131.64 $6.22 Million - $9.95 Million	-75,551 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$76.53 - $135.58 $1.38 Million - $2.44 Million	18,000 Added 31.28%	75,551 $8.69 Million
Q3 2019 Nov 08, 2019	BUY	$72.81 - $156.91 $4.19 Million - $9.03 Million	57,551 New	57,551 $3.98 Million

530

84.5M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $12.1B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

Stay updated on Apg Asset Management N.V. with notifications on news.